Related Experiment Video
Updated: Oct 5, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Presence of Microvascular Dysfunction and CHA2DS2-VASc Score in Patients with ST-Segment Myocardial Infarction after
Ragab A Mahfouz1, Marwa M Gad1, Mohamed Arab1
1Cardiology Department, Zagazig University Hospital, Zagazig, Egypt.
Insights
The CHA2DS2-VASc score can predict microvascular dysfunction (MVD) after ST-segment elevation myocardial infarction (STEMI) treatment. A higher score indicates increased MVD risk following primary percutaneous intervention (PPCI).
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Microvascular dysfunction (MVD) is a complication after primary percutaneous intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI).
- Assessing MVD risk is crucial for optimizing patient outcomes.
- The CHA2DS2-VASc score is a validated risk stratification tool in cardiovascular disease.
Purpose of the Study:
- To investigate the relationship between the CHA2DS2-VASc score and microvascular resistance (IMR) in STEMI patients post-PPCI.
- To determine if the CHA2DS2-VASc score can predict MVD, assessed by IMR, immediately after PPCI.
Main Methods:
- A study of 115 STEMI patients undergoing successful PPCI.
- Assessment of microvascular resistance (IMR) using the index of microvascular resistance.
- Correlation analysis between CHA2DS2-VASc score, IMR, and echocardiographic parameters.
Main Results:
- Patients with higher IMR (≥40 U) exhibited significantly higher CHA2DS2-VASc scores (p < 0.001).
- CHA2DS2-VASc score strongly correlated with increased IMR and indicators of cardiac dysfunction.
- Multivariate analysis identified CHA2DS2-VASc score ≥4 as optimal for predicting MVD (IMR ≥40) in STEMI patients.
Conclusions:
- Increased CHA2DS2-VASc score is associated with a higher incidence of MVD (elevated IMR) after PPCI in STEMI.
- The CHA2DS2-VASc score may serve as a practical, cost-effective tool for predicting MVD risk in these patients.
- Lower systolic blood pressure and stent diameter also correlate with MVD post-PPCI.
Objective:
We aimed to investigate the relation between CHA2DS2-VASc score and microvascular dysfunction (MVD) assessed by the index of microvascular resistance (IMR) immediately after primary percutaneous intervention (PPCI) for patients with ST-segment elevation myocardial infarction (STEMI).
Subjects And Methods:
The study included 115 consecutive patients with STEMI who underwent successful PPCI. Angiographic results of reperfusion were inspected to evaluate the association of high CHA2DS2-VASc score and IMR. Also, we assessed echocardiographic changes with respect to CHA2DS2-VASc score.
Results:
Subjects were stratified into 2 groups based on IMR ≥ 40 U; 72 patients (62.6) with IMR <40 U and 43 patients (37.4) with IMR ≥40 U. Patients with IMR ≥40 U had higher CHA2DS2-VASc score (p < 0.001). CHA2DS2-VASc score was significantly correlated with increased left atrial volume index, diastolic dysfunction, wall motion score index, and inversely correlated left ventricular ejection. Moreover, CHA2DS2-VASc score was strongly correlated with IMR (p < 0.001). At multivariate analysis, low systolic blood pressure, stent diameter, and CHA2DS2-VASc score were associated with MVD. Besides, CHA2DS2-VASc score ≥4 was the optimal value in predicting MVD (IMR ≥40) in STEMI patients.
Conclusions:
The data of the current study point out that increased CHA2DS2-VASc score, lower systolic blood pressure <90 mm Hg, and stent diameter are associated with increased incidence of MVD (increased IMR) after PPCI of STEMI. We suggest that the CHA2DS2-VASc score may be a simple, inexpensive useful risk score for the prediction of MVD risk after PPCI for STEMI patients.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...

